Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 14 studies | 40% ± 18% | |
basal cell | 8 studies | 31% ± 16% | |
astrocyte | 8 studies | 34% ± 24% | |
endothelial cell of lymphatic vessel | 7 studies | 42% ± 15% | |
cardiac muscle cell | 5 studies | 22% ± 5% | |
ciliated cell | 5 studies | 30% ± 10% | |
glutamatergic neuron | 4 studies | 21% ± 4% | |
GABAergic neuron | 3 studies | 28% ± 3% | |
endothelial cell | 3 studies | 45% ± 29% | |
epithelial cell | 3 studies | 25% ± 10% | |
hepatocyte | 3 studies | 40% ± 11% | |
myofibroblast cell | 3 studies | 38% ± 15% | |
respiratory goblet cell | 3 studies | 46% ± 23% | |
smooth muscle cell | 3 studies | 29% ± 7% | |
interneuron | 3 studies | 26% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 21% ± 0% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 11497.47 | 1445 / 1445 | 80% | 21.83 | 147 / 183 |
uterus | 93% | 2466.93 | 158 / 170 | 63% | 16.34 | 288 / 459 |
brain | 49% | 698.75 | 1297 / 2642 | 99% | 66.51 | 697 / 705 |
breast | 75% | 1545.74 | 343 / 459 | 71% | 12.46 | 789 / 1118 |
stomach | 97% | 4572.85 | 347 / 359 | 39% | 9.32 | 111 / 286 |
lung | 69% | 1124.76 | 401 / 578 | 63% | 15.02 | 730 / 1155 |
intestine | 96% | 3632.78 | 930 / 966 | 25% | 3.63 | 131 / 527 |
prostate | 75% | 1112.22 | 184 / 245 | 44% | 4.32 | 219 / 502 |
bladder | 90% | 3008.57 | 19 / 21 | 25% | 4.22 | 124 / 504 |
liver | 63% | 862.95 | 142 / 226 | 48% | 5.27 | 193 / 406 |
blood vessel | 90% | 6449.92 | 1199 / 1335 | 0% | 0 | 0 / 0 |
ovary | 6% | 126.17 | 11 / 180 | 83% | 19.43 | 358 / 430 |
tonsil | 0% | 0 | 0 / 0 | 89% | 31.38 | 40 / 45 |
heart | 86% | 7567.32 | 738 / 861 | 0% | 0 | 0 / 0 |
skin | 66% | 1467.13 | 1200 / 1809 | 17% | 2.35 | 80 / 472 |
pancreas | 10% | 94.93 | 32 / 328 | 51% | 8.60 | 91 / 178 |
adipose | 54% | 1152.90 | 649 / 1204 | 0% | 0 | 0 / 0 |
thymus | 30% | 371.62 | 193 / 653 | 14% | 7.46 | 85 / 605 |
kidney | 19% | 205.31 | 17 / 89 | 12% | 5.90 | 106 / 901 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.65 | 3 / 29 |
adrenal gland | 0% | 6.17 | 1 / 258 | 9% | 2.01 | 21 / 230 |
muscle | 5% | 58.41 | 42 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.14 | 1 / 80 |
peripheral blood | 1% | 6.84 | 6 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007265 | Biological process | Ras protein signal transduction |
GO_0045773 | Biological process | positive regulation of axon extension |
GO_0060252 | Biological process | positive regulation of glial cell proliferation |
GO_1903975 | Biological process | regulation of glial cell migration |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_2000147 | Biological process | positive regulation of cell motility |
GO_0060603 | Biological process | mammary gland duct morphogenesis |
GO_0097475 | Biological process | motor neuron migration |
GO_0033564 | Biological process | anterior/posterior axon guidance |
GO_0006930 | Biological process | substrate-dependent cell migration, cell extension |
GO_0051963 | Biological process | regulation of synapse assembly |
GO_0007097 | Biological process | nuclear migration |
GO_0042472 | Biological process | inner ear morphogenesis |
GO_0006915 | Biological process | apoptotic process |
GO_0030517 | Biological process | negative regulation of axon extension |
GO_0032488 | Biological process | Cdc42 protein signal transduction |
GO_0061643 | Biological process | chemorepulsion of axon |
GO_0098609 | Biological process | cell-cell adhesion |
GO_0014009 | Biological process | glial cell proliferation |
GO_0005576 | Cellular component | extracellular region |
GO_0005654 | Cellular component | nucleoplasm |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0005604 | Cellular component | basement membrane |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0005515 | Molecular function | protein binding |
Gene name | NTN1 |
Protein name | Netrin 1 Netrin-1 (Epididymis tissue protein Li 131P) |
Synonyms | NTN1L |
Description | FUNCTION: Netrins control guidance of CNS commissural axons and peripheral motor axons. Its association with either DCC or some UNC5 receptors will lead to axon attraction or repulsion, respectively. Binding to UNC5C might cause dissociation of UNC5C from polymerized TUBB3 in microtubules and thereby lead to increased microtubule dynamics and axon repulsion . Involved in dorsal root ganglion axon projection towards the spinal cord . It also serves as a survival factor via its association with its receptors which prevent the initiation of apoptosis. Involved in tumorigenesis by regulating apoptosis . . |
Accessions | ENST00000173229.7 ENST00000436734.1 O95631 H7BZF4 |